Therapeutic interruption of advanced glycation in diabetic nephropathy: Do all roads lead to Rome?

Annals of the New York Academy of Sciences

Volumn 1126, Issue , 2008, Pages 101-106

  Sourris, Karly C ^a   Forbes, Josephine M ^a   Cooper, Mark E ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Advanced glycation end products; Diabetic nephropathy; Reactive oxygen species; Receptor for advanced glycation end products

Indexed keywords

2 ISOPROPYLIDENEHYDRAZONO 4 OXO 5 THIAZOLIDINYLACETANILIDE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ADVANCED GLYCATION END PRODUCT; ALAGEBRIUM; AMINOGUANIDINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIOXIDANT; BENFOTIAMINE; CARNOSINE; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METFORMIN; PYRIDOXAMINE; REACTIVE OXYGEN METABOLITE; THIAMINE;

CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE COURSE; DRUG INHIBITION; DRUG MECHANISM; GLYCATION; GLYCEMIC CONTROL; HEMODYNAMICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN INJURY; SIGNAL TRANSDUCTION;

EID: 42549110364     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1433.048     Document Type: Conference Paper

References (49)